Developer docs
API playgroundTry for free, no card

Search company profiles

Pharmaledger

Full company profile

uuid000m5r9

Namestring
Pharmaledger
Legal namestring
PharmaLedger Association
Company typeenum
Private
Founded yearint
2022
Descriptiontext

PharmaLedger Association (PLA) is a Swiss non-profit membership association, registered in Basel under Swiss Civil Code (CHE-178.875.143) and operating a Digital Trust Ecosystem in Healthcare (DTE-H). Founded in March 2022 as the post-project sustainability vehicle for the EU-funded PharmaLedger Project (2020-2022, Innovative Medicines Initiative), PLA builds and operates open-source blockchain infrastructure that serves pharmaceutical manufacturers (GSK, MSD, AbbVie, Takeda, Elanco, Moderna), distributors (Zuellig Pharma), healthcare providers, patients, regulatory authorities, clinical research organizations, and academic institutions. Its mission centers on pre-competitive, vendor-agnostic collaboration to address counterfeit medicines, supply chain opacity, fragmented product information, and clinical trial inefficiencies that no single organization can solve alone.

The technical core is the Product Trust Platform™, which uses blockchain as a resolver for product identification via GTIN barcodes, with a GxP-qualified, ISO 9001-aligned infrastructure compliant with 21 CFR Part 11, EU Annex 11, and 21 CFR 820. Building on this platform, PLA offers ePI by PharmaLedger™ (a mobile app delivering electronic product information across 46 countries in 29 languages, launched April 2023), AstraLabel™ (a SaaS digital labelling platform with Core, Solo, and Edge deployment models launching commercially in January 2026), AstraTrace™ (supply chain inventory visibility), and clinical trial modules including eConsent, eEnrollment, and IoT medical device integration. Digital twin technology with IoT sensor inputs and AI-based anomaly detection supports end-to-end supply chain traceability.

Revenue is generated through annual membership fees across four tiers (Patron, Standard, Public, Patient Organization), service contracts for AstraLabel deployment and technical infrastructure management, and event sponsorships. At least 5% of membership fee income is allocated to innovation activities. The association is governed by a Board elected from patron, standard, public, and patient organization members, with the Executive Director reporting to the Board. Operations are anchored in Basel, Switzerland, with a documented team of approximately 10-20 core personnel supplemented by contractors and member-organization contributors.

Short descriptiontext

PharmaLedger Association is a Swiss non-profit building a blockchain-based Digital Trust Ecosystem in Healthcare. It serves pharmaceutical manufacturers, providers, patients, and regulators with electronic product information, supply chain traceability, and a GxP-qualified open-source blockchain platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBasel, Switzerland
HQ citystring
Basel
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
blockchain healthcare platform, digital product labelling, supply chain traceability, decentralized clinical trials, electronic product information
Industry4 codes
PRIMARYHLACAIAG
Consent, Preference & Data Rights Management (incl. HIPAA/GDPR support)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation
SECONDARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLAIAKAL
Access Policy, Advocacy & Stakeholder Management
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
NAICS code2 codes
  • Software Publishers51321
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Healthcare Blockchain Platforms
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Membership Fees
TypeSubscription Recurring
Description

The association generates revenue through membership fees from patron, standard, public, and patient organization members. Fees are confirmed annually by the General Assembly. At least 5% of membership fee income finances innovation activities.

pharmaledger.org
2Service Contracts
TypeProfessional Services
Description

PLA provides services including product deployment, implementation support, and technical infrastructure management for members and clients using AstraLabel and other platforms.

pharmaledger.org
3Events and Sponsorships
TypeManaged Services
Description

Revenue generated from hosting and participating in events, webinars, and conferences in the healthcare and blockchain space.

pharmaledger.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Membership tiers: Patron, Standard, Public, and Patient Organization
ModelSubscriptionBilling cadenceAnnual
Notes

Membership fees are confirmed annually by the General Assembly. The association offers different membership categories to accommodate pharmaceutical companies, SMEs, patient organizations, universities, wholesalers/distributors, and industry associations.

pharmaledger.org
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1AstraLabel
Description

Compliant digital labelling and ePI platform for regulators and manufacturers. A SaaS platform enabling real-time, secure delivery of approved labelling content to packaging, supply chain operations, regulatory portals, and patient/HCP devices. Available in Core, Solo, and Edge deployment models.

pharmaledger.org
+4 more records
Core offering1 text field

PharmaLedger Association (PLA) operates a blockchain-based Digital Trust Ecosystem in Healthcare (DTE-H) that delivers open-source platforms for digital pharmaceutical labelling (AstraLabel), electronic product information delivery (ePI), and supply chain inventory visibility (AstraTrace). The association sells SaaS deployment access and provides professional services to pharmaceutical manufacturers, healthcare providers, and clinical research organizations across 46 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • ePI by PharmaLedger deployed across 46 countries in 29 languages
+3 more records
Product overview1 text field

PharmaLedger Association operates as a non-profit organization building a Digital Trust Ecosystem in Healthcare (DTE-H) through a portfolio of interconnected blockchain-powered products. The core platform is the Product Trust Platform™, which hosts AstraLabel™ as the primary SaaS offering (launching 2026) for digital labelling and ePI deployment. The primary end-user product is ePI by PharmaLedger™, a mobile application providing electronic product information via barcode scanning. AstraTrace™ delivers supply chain inventory visibility. Additional offerings include eConsent, eEnrollment, and IoT Medical Devices Integration for decentralized clinical trials. AstraLabel™ serves as the unified engine powering AstraTrace™ and ePI, with deployment models (Core, Solo, Edge) supporting organizations of varying scale and digital maturity.

Product and service8 records
1AstraLabel™
CategoryDigital Labelling Platform
Description

SaaS platform for compliant digital labelling and ePI deployment that enables real-time, secure delivery of approved labelling content directly to packaging, supply chain operations, regulatory portals, and patient/HCP devices. Designed for regulatory traceability, data privacy, zero-paper operations, and interoperability.

2ePI by PharmaLedger™
CategoryElectronic Product Information
Description

Mobile application delivering real-time SmPC, ePIL, and labelling content to patients and healthcare practitioners via barcode scanning on product packaging. Accessible without download or registration; currently operational in 46 countries and 29 languages.

3AstraTrace™
CategorySupply Chain Traceability
Description

Inventory visibility solution providing near real-time tracking across the pharmaceutical supply chain, enhancing patient safety, reducing medication waste, and ensuring integrity of medicines from production to patient.

4Product Trust Platform™
CategoryBlockchain Infrastructure
Description

Underlying blockchain-based platform that powers PLA's digital solutions including ePI and supply chain traceability. Ensures tamper-evident records and transparent product information exchange across the Digital Trust Ecosystem in Healthcare.

5eConsent (Decentralized Clinical Trials)
CategoryClinical Trial Solutions
Description

Blockchain-based informed consent platform for clinical trials providing secure, transparent, and traceable consent data management with decentralized data distribution across multiple nodes.

6eEnrollment/eRecruitment
CategoryClinical Trial Solutions
Description

Neutral, sponsor-agnostic platform for participant matching in clinical trials using advanced search capabilities and personalized recommendations to help match patients with suitable trials.

7IoT Medical Devices Integration
CategoryClinical Trial Solutions
Description

Enables real-time data acquisition and processing directly from participant IoT medical devices to researchers, supporting personalized medicine through continuous health monitoring, treatment adherence tracking, and adverse event identification.

8Product Trust Platform 2.0
CategoryBlockchain Infrastructure
Description

Next-generation blockchain infrastructure for global product traceability and patient safety that will power AstraLabel and other PLA solutions from January 2026.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership21 partners
Strategic tierCoreTypeTechnology or Integration
Description

PLA partnered with Glemser Technologies, a PLA member company, to provide seamless XML conversion services at scale for AstraLabel customers. Glemser manages XML to ePI conversion activities ensuring compliance and governance while PharmaLedger provides the validated technology platform.

Strategic tierCoreTypeTechnology or Integration
Description

PDMFC, a PLA member company, was selected as the development partner for Product Trust Platform 2.0. Under PLA's leadership, PDMFC is building the next-generation infrastructure that will power AstraLabel serving PLA members and clients starting January 2026.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

British multinational pharmaceutical and biotechnology company and Patron member of PharmaLedger Association, contributing to governance and strategic direction of the Digital Trust Ecosystem.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

American multinational pharmaceutical company and Patron member. Hosted ePI technical workshop at Prague offices in May 2023. Contributes to association governance and product development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical Research & Development company and member of PharmaLedger, participating in association governance and ecosystem initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Japanese multinational pharmaceutical company and member contributing to Digital Trust Ecosystem initiatives and governance.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Animal health pharmaceutical company and member of PharmaLedger Association participating in ecosystem activities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare distribution, commercialisation, technology, clinical trial management, and patient care company. Member representing distributor/wholesaler perspective in ecosystem.

Strategic tierCoreTypeTechnology or Integration
Description

Privacy and scalability blockchain technology provider. Provides blockchain infrastructure expertise for the GxP-qualified network and Product Trust Platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Patient organization representing patients' interests in healthcare. Co-designs patient-centric solutions like ePI and provides patient perspective in governance.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Centre for Research & Technology Hellas - research institution contributing academic expertise to ecosystem projects.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Italian consortium contributing to pharmaceutical supply chain and traceability initiatives.

13University of Thrace
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic institution (Democritus University of Thrace) contributing research capabilities to ecosystem projects.

pharmaledger.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic institution member contributing research and education to healthcare blockchain initiatives.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Pharmaceutical packaging company providing expertise in smart packaging and serialization for supply chain traceability.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Member organization contributing to pharmaceutical information and labelling initiatives.

17activeage.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Organization focused on active aging contributing patient-centered perspective to ecosystem.

pharmaledger.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare access and medicine distribution company contributing to pharmaceutical access initiatives.

19ZVEZA Organizacij pacientov Slovenija
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Slovenian patient organization representing patient interests in healthcare ecosystem.

pharmaledger.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Biopharmaceutical company and member contributing to vaccine and therapeutic product trust initiatives.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Industry association providing supply chain expertise and standards knowledge to ecosystem.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

TraceLink provides pharmaceutical supply chain traceability and serialization software, including blockchain-enabled network solutions for track-and-trace and product verification. It is a direct competitor to PLA's AstraTrace and Product Trust Platform in pharma supply chain visibility.

TypeDirect peer
Description

Optel provides pharmaceutical serialization, traceability, and supply chain visibility solutions including digital label and packaging intelligence, overlapping directly with AstraTrace and AstraLabel use cases.

TypeBroad incumbent
Description

Veeva provides cloud-based content management, regulatory, and quality solutions for the pharmaceutical industry, and is already integrated with AstraLabel. It is a broad incumbent that could compete with or distribute PLA's digital labelling capabilities.

4Movemedical
TypeEmerging player
Description

Movemedical offers cloud-based software for medical device sales, inventory, and supply chain management. It is an emerging adjacent player with comparable focus on medical product traceability, though oriented toward medtech rather than pharma.

TypeEmerging player
Description

Truveta aggregates de-identified clinical data from health systems and partners with life sciences companies on research and analytics. It is an emerging player in healthcare data platforms with thematic overlap to PLA's data-driven DTE-H vision.

TypeBroad incumbent
Description

SAP provides enterprise resource planning and supply chain software widely used across pharmaceutical manufacturers, with AstraLabel integrating into SAP. As a broad incumbent, SAP could embed equivalent digital labelling and traceability functionality natively.

TypeDirect peer
Description

Partisia provides the underlying privacy-focused blockchain infrastructure that powers PLA's GxP-qualified network. It is both a technology partner and a peer in the enterprise blockchain-for-healthcare category.

TypeBroad incumbent
Description

IQVIA is a large provider of clinical research, data, and technology services to the pharmaceutical industry. Its clinical trial and real-world data capabilities overlap with PLA's decentralized clinical trials (eConsent, eEnrollment, IoT) offerings.

TypeDirect peer
Description

Antares Vision, including the Rfxcel acquisition, provides serialization, traceability, and digitalization solutions for the pharmaceutical and life sciences industries. It directly overlaps with PLA's supply chain traceability and digital labelling positioning.

TypeDirect peer
Description

MediLedger, built on blockchain infrastructure, focuses on pharma supply chain provenance and chargeback management. It is one of the closest functional analogues to PLA's blockchain-based pharma trust ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharmaledger

Healthcare Blockchain Platformspharmaledger.org

PharmaLedger Association is a Swiss non-profit building a blockchain-based Digital Trust Ecosystem in Healthcare. It serves pharmaceutical manufacturers, providers, patients, and regulators with electronic product information, supply chain traceability, and a GxP-qualified open-source blockchain platform.

What Pharmaledger does

PharmaLedger Association (PLA) is a Swiss non-profit membership association, registered in Basel under Swiss Civil Code (CHE-178.875.143) and operating a Digital Trust Ecosystem in Healthcare (DTE-H). Founded in March 2022 as the post-project sustainability vehicle for the EU-funded PharmaLedger Project (2020-2022, Innovative Medicines Initiative), PLA builds and operates open-source blockchain infrastructure that serves pharmaceutical manufacturers (GSK, MSD, AbbVie, Takeda, Elanco, Moderna), distributors (Zuellig Pharma), healthcare providers, patients, regulatory authorities, clinical research organizations, and academic institutions. Its mission centers on pre-competitive, vendor-agnostic collaboration to address counterfeit medicines, supply chain opacity, fragmented product information, and clinical trial inefficiencies that no single organization can solve alone.

The technical core is the Product Trust Platform™, which uses blockchain as a resolver for product identification via GTIN barcodes, with a GxP-qualified, ISO 9001-aligned infrastructure compliant with 21 CFR Part 11, EU Annex 11, and 21 CFR 820. Building on this platform, PLA offers ePI by PharmaLedger™ (a mobile app delivering electronic product information across 46 countries in 29 languages, launched April 2023), AstraLabel™ (a SaaS digital labelling platform with Core, Solo, and Edge deployment models launching commercially in January 2026), AstraTrace™ (supply chain inventory visibility), and clinical trial modules including eConsent, eEnrollment, and IoT medical device integration. Digital twin technology with IoT sensor inputs and AI-based anomaly detection supports end-to-end supply chain traceability.

Revenue is generated through annual membership fees across four tiers (Patron, Standard, Public, Patient Organization), service contracts for AstraLabel deployment and technical infrastructure management, and event sponsorships. At least 5% of membership fee income is allocated to innovation activities. The association is governed by a Board elected from patron, standard, public, and patient organization members, with the Executive Director reporting to the Board. Operations are anchored in Basel, Switzerland, with a documented team of approximately 10-20 core personnel supplemented by contractors and member-organization contributors.

Pharmaledger firmographics

Firmographics
Name
Pharmaledger
Legal name
PharmaLedger Association
Website
https://pharmaledger.org
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
PharmaLedger Association is a Swiss non-profit building a blockchain-based Digital Trust Ecosystem in Healthcare. It serves pharmaceutical manufacturers, providers, patients, and regulators with electronic product information, supply chain traceability, and a GxP-qualified open-source blockchain platform.
Ownership category
akta.pro rank

Pharmaledger industry classification

Industry
Product category
Healthcare Blockchain Platforms
NAICS
Software Publishers (51321), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLACAIAG
Consent, Preference & Data Rights Management (incl. HIPAA/GDPR support)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation
SECONDARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLAIAKAL
Access Policy, Advocacy & Stakeholder Management
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing

Keywords

  • Blockchain healthcare platform
  • Digital product labelling
  • Supply chain traceability
  • Decentralized clinical trials
  • Electronic product information

Where Pharmaledger is headquartered

Location

Headquarters

HQ city
Basel
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Pharmaledger business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Membership Fees: The association generates revenue through membership fees from patron, standard, public, and patient organization members. Fees are confirmed annually by the General Assembly. At least 5% of membership fee income finances innovation activities.
  2. Service Contracts: PLA provides services including product deployment, implementation support, and technical infrastructure management for members and clients using AstraLabel and other platforms.
  3. Events and Sponsorships: Revenue generated from hosting and participating in events, webinars, and conferences in the healthcare and blockchain space.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualMembership tiers: Patron, Standard, Public, and Patient Organization

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Pharmaledger product offering

Product offering

Core offering

PharmaLedger Association (PLA) operates a blockchain-based Digital Trust Ecosystem in Healthcare (DTE-H) that delivers open-source platforms for digital pharmaceutical labelling (AstraLabel), electronic product information delivery (ePI), and supply chain inventory visibility (AstraTrace). The association sells SaaS deployment access and provides professional services to pharmaceutical manufacturers, healthcare providers, and clinical research organizations across 46 countries.

Product overview

PharmaLedger Association operates as a non-profit organization building a Digital Trust Ecosystem in Healthcare (DTE-H) through a portfolio of interconnected blockchain-powered products. The core platform is the Product Trust Platform™, which hosts AstraLabel™ as the primary SaaS offering (launching 2026) for digital labelling and ePI deployment. The primary end-user product is ePI by PharmaLedger™, a mobile application providing electronic product information via barcode scanning. AstraTrace™ delivers supply chain inventory visibility. Additional offerings include eConsent, eEnrollment, and IoT Medical Devices Integration for decentralized clinical trials. AstraLabel™ serves as the unified engine powering AstraTrace™ and ePI, with deployment models (Core, Solo, Edge) supporting organizations of varying scale and digital maturity.

Differentiator

Problem solved

Functional benefit

Brands

  • AstraLabel: Compliant digital labelling and ePI platform for regulators and manufacturers. A SaaS platform enabling real-time, secure delivery of approved labelling content to packaging, supply chain operations, regulatory portals, and patient/HCP devices. Available in Core, Solo, and Edge deployment models.
  • AstraTrace
  • ePI by PharmaLedger
  • Product Trust Platform
  • Digital Trust Ecosystem in Healthcare (DTE-H)

Products and services

  • AstraLabel™ SaaS platform for compliant digital labelling and ePI deployment that enables real-time, secure delivery of approved labelling content directly to packaging, supply chain operations, regulatory portals, and patient/HCP devices. Designed for regulatory traceability, data privacy, zero-paper operations, and interoperability.
  • ePI by PharmaLedger™ Mobile application delivering real-time SmPC, ePIL, and labelling content to patients and healthcare practitioners via barcode scanning on product packaging. Accessible without download or registration; currently operational in 46 countries and 29 languages.
  • AstraTrace™ Inventory visibility solution providing near real-time tracking across the pharmaceutical supply chain, enhancing patient safety, reducing medication waste, and ensuring integrity of medicines from production to patient.
  • Product Trust Platform™ Underlying blockchain-based platform that powers PLA's digital solutions including ePI and supply chain traceability. Ensures tamper-evident records and transparent product information exchange across the Digital Trust Ecosystem in Healthcare.
  • eConsent (Decentralized Clinical Trials) Blockchain-based informed consent platform for clinical trials providing secure, transparent, and traceable consent data management with decentralized data distribution across multiple nodes.
  • eEnrollment/eRecruitment Neutral, sponsor-agnostic platform for participant matching in clinical trials using advanced search capabilities and personalized recommendations to help match patients with suitable trials.
  • IoT Medical Devices Integration Enables real-time data acquisition and processing directly from participant IoT medical devices to researchers, supporting personalized medicine through continuous health monitoring, treatment adherence tracking, and adverse event identification.
  • Product Trust Platform 2.0 Next-generation blockchain infrastructure for global product traceability and patient safety that will power AstraLabel and other PLA solutions from January 2026.

Quantifiable outcome

  • ePI by PharmaLedger deployed across 46 countries in 29 languages
  • +3 more outcomes

Companies that use Pharmaledger

Customer profile

Named customers1 record

Segments6 records

Ideal customer profiles3 records

Pharmaledger technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature5 records

Pharmaledger partnerships and signals

Strategic signal

Partnerships

21 partnerships are on record, tiered core and minor.

  • Glemser TechnologiescoreTechnology or IntegrationPLA partnered with Glemser Technologies, a PLA member company, to provide seamless XML conversion services at scale for AstraLabel customers. Glemser manages XML to ePI conversion activities ensuring compliance and governance while PharmaLedger provides the validated technology platform.
  • PDMFCcoreTechnology or IntegrationPDMFC, a PLA member company, was selected as the development partner for Product Trust Platform 2.0. Under PLA's leadership, PDMFC is building the next-generation infrastructure that will power AstraLabel serving PLA members and clients starting January 2026.
  • GSKcoreStrategic or Co-development PartnerBritish multinational pharmaceutical and biotechnology company and Patron member of PharmaLedger Association, contributing to governance and strategic direction of the Digital Trust Ecosystem.
  • MSD (Merck & Co.)coreStrategic or Co-development PartnerAmerican multinational pharmaceutical company and Patron member. Hosted ePI technical workshop at Prague offices in May 2023. Contributes to association governance and product development.
  • AbbViecoreStrategic or Co-development PartnerPharmaceutical Research & Development company and member of PharmaLedger, participating in association governance and ecosystem initiatives.
  • TakedacoreStrategic or Co-development PartnerJapanese multinational pharmaceutical company and member contributing to Digital Trust Ecosystem initiatives and governance.
  • ElancominorStrategic or Co-development PartnerAnimal health pharmaceutical company and member of PharmaLedger Association participating in ecosystem activities.
  • Zuellig PharmacoreStrategic or Co-development PartnerHealthcare distribution, commercialisation, technology, clinical trial management, and patient care company. Member representing distributor/wholesaler perspective in ecosystem.
  • Partisia BlockchaincoreTechnology or IntegrationPrivacy and scalability blockchain technology provider. Provides blockchain infrastructure expertise for the GxP-qualified network and Product Trust Platform.
  • European Patients ForumcoreStrategic or Co-development PartnerPatient organization representing patients' interests in healthcare. Co-designs patient-centric solutions like ePI and provides patient perspective in governance.
  • CERTHminorStrategic or Co-development PartnerCentre for Research & Technology Hellas - research institution contributing academic expertise to ecosystem projects.
  • Consorzio DafneminorStrategic or Co-development PartnerItalian consortium contributing to pharmaceutical supply chain and traceability initiatives.
  • University of ThraceminorStrategic or Co-development PartnerAcademic institution (Democritus University of Thrace) contributing research capabilities to ecosystem projects.
  • Michigan State UniversityminorStrategic or Co-development PartnerAcademic institution member contributing research and education to healthcare blockchain initiatives.
  • allpack Pharma PackagingminorStrategic or Co-development PartnerPharmaceutical packaging company providing expertise in smart packaging and serialization for supply chain traceability.
  • INCMminorStrategic or Co-development PartnerMember organization contributing to pharmaceutical information and labelling initiatives.
  • activeage.orgminorStrategic or Co-development PartnerOrganization focused on active aging contributing patient-centered perspective to ecosystem.
  • MED ADITUSminorStrategic or Co-development PartnerHealthcare access and medicine distribution company contributing to pharmaceutical access initiatives.
  • ZVEZA Organizacij pacientov SlovenijaminorStrategic or Co-development PartnerSlovenian patient organization representing patient interests in healthcare ecosystem.
  • ModernaminorStrategic or Co-development PartnerBiopharmaceutical company and member contributing to vaccine and therapeutic product trust initiatives.
  • Council of Supply Chain Management Professionals (CSCM)minorStrategic or Co-development PartnerIndustry association providing supply chain expertise and standards knowledge to ecosystem.

Scale indicators4 records

Recent moves10 records

Expansion highlights6 records

Pharmaledger competitors and assessment

Company assessment

Direct peers

  • TraceLink: TraceLink provides pharmaceutical supply chain traceability and serialization software, including blockchain-enabled network solutions for track-and-trace and product verification. It is a direct competitor to PLA's AstraTrace and Product Trust Platform in pharma supply chain visibility.
  • Optel Group: Optel provides pharmaceutical serialization, traceability, and supply chain visibility solutions including digital label and packaging intelligence, overlapping directly with AstraTrace and AstraLabel use cases.
  • Partisia Blockchain: Partisia provides the underlying privacy-focused blockchain infrastructure that powers PLA's GxP-qualified network. It is both a technology partner and a peer in the enterprise blockchain-for-healthcare category.
  • Antares Vision Group (Rfxcel): Antares Vision, including the Rfxcel acquisition, provides serialization, traceability, and digitalization solutions for the pharmaceutical and life sciences industries. It directly overlaps with PLA's supply chain traceability and digital labelling positioning.
  • MediLedger (Chronicled): MediLedger, built on blockchain infrastructure, focuses on pharma supply chain provenance and chargeback management. It is one of the closest functional analogues to PLA's blockchain-based pharma trust ecosystem.

Broad incumbents

  • Veeva Systems: Veeva provides cloud-based content management, regulatory, and quality solutions for the pharmaceutical industry, and is already integrated with AstraLabel. It is a broad incumbent that could compete with or distribute PLA's digital labelling capabilities.
  • SAP Healthcare: SAP provides enterprise resource planning and supply chain software widely used across pharmaceutical manufacturers, with AstraLabel integrating into SAP. As a broad incumbent, SAP could embed equivalent digital labelling and traceability functionality natively.
  • IQVIA: IQVIA is a large provider of clinical research, data, and technology services to the pharmaceutical industry. Its clinical trial and real-world data capabilities overlap with PLA's decentralized clinical trials (eConsent, eEnrollment, IoT) offerings.

Emerging players

  • Movemedical: Movemedical offers cloud-based software for medical device sales, inventory, and supply chain management. It is an emerging adjacent player with comparable focus on medical product traceability, though oriented toward medtech rather than pharma.
  • Truveta: Truveta aggregates de-identified clinical data from health systems and partners with life sciences companies on research and analytics. It is an emerging player in healthcare data platforms with thematic overlap to PLA's data-driven DTE-H vision.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Pharmaledger social profiles

Digital presence

Pharmaledger compliance and trust

Trust signal

Compliance7 records

Pharmaledger financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharmaledger leadership team

Management profile

Number of profiles

Profiles5 records

Pharmaledger funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharmaledger M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaledger

What does Pharmaledger do?

PharmaLedger Association (PLA) operates a blockchain-based Digital Trust Ecosystem in Healthcare (DTE-H) that delivers open-source platforms for digital pharmaceutical labelling (AstraLabel), electronic product information delivery (ePI), and supply chain inventory visibility (AstraTrace). The association sells SaaS deployment access and provides professional services to pharmaceutical manufacturers, healthcare providers, and clinical research organizations across 46 countries.

Is Pharmaledger a public or private company?

Pharmaledger is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Pharmaledger founded?

Pharmaledger was founded in 2022. It employs 1 to 10 people.

Where is Pharmaledger based?

Pharmaledger is headquartered in Basel, Switzerland, in the Europe region.

How does Pharmaledger make money?

Three revenue lines are on record. Membership Fees are the primary driver. The others are service Contracts and events and Sponsorships.

Who are Pharmaledger's main competitors?

Direct peers on record are TraceLink, Optel Group, Partisia Blockchain, Antares Vision Group (Rfxcel) and MediLedger (Chronicled). Broad incumbents are Veeva Systems, SAP Healthcare and IQVIA. Emerging players are Movemedical and Truveta.

Does Pharmaledger have an API?

No public API is recorded for Pharmaledger.

What industry is Pharmaledger in?

Pharmaledger's product category is Healthcare Blockchain Platforms. Its primary akta.pro industry code is HLACAIAG, Consent, Preference & Data Rights Management (incl. HIPAA/GDPR support), with a secondary code of BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation. Its NAICS code is 51321 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CiotechworldBlockchain: Enhancing Transparency and Traceability in Supply ChainAn explanatory article by Raj Grover outlines how blockchain's immutability, decentralization and transparency address opacity, fraud and counterfeiting in global supply chains. It details technical elements such as distributed ledgers, smart contracts, consensus mechanisms and cryptographic hashing, plus use cases including Nestl\u00e9, Anheuser-Busch InBev, PharmaLedger, JPMorgan, LVMH, FedEx, De Beers and BHP Billiton. The author notes remaining challenges in scalability, interoperability, data privacy and adoption.PharmaledgerDecentralized Trials: A Blockchain-Driven Pharmaceutical EvolutionPharmaLedger describes its Decentralized Trials Project, which integrates blockchain into clinical trials through eEnrollment/eRecruitment, eConsent, and IoT Medical Devices. The company cites blockchain's immutability and decentralization as safeguards against data falsification, manual error and security breaches, and promises real-time real-world data access. It states the eConsent component is set to launch soon.PR NewswirePharmaLedger llega a más de 30 miembros que demuestran la tendencia del ecosistema en salud digitalThe PharmaLedger Association announced the onboarding of over 30 new members, including major pharmaceutical firms like Takeda and healthcare service provider Zuellig Pharma, as well as technology and academic institutions. This expansion reinforces the association's role in fostering a trusted digital ecosystem for healthcare supply chains, clinical trials, and data spaces. The growth highlights increasing industry acceptance of shared digital infrastructure to improve transparency and efficiency in health studies.GlobeNewswirePharmaLedger Association Launches Digital Trust Ecosystem in HealthcareThe PharmaLedger Association endorsed its 3-year strategic plan to implement a Digital Trust Ecosystem in healthcare at its March 1, 2023 annual meeting. It will release its first qualified product, electronic Product Information, in Q1 2023, with further products planned in Q2. The association was formed from a €22 million EU-funded research project.GlobeNewswirePharmaLedger Association Launches Digital Trust Ecosystem in HealthcareThe PharmaLedger Association endorsed its 3-year strategic plan to implement a Digital Trust Ecosystem in healthcare at its March 1, 2023 annual meeting. It will release its first qualified product, electronic Product Information, in Q1 2023, with further products planned in Q2. The association was formed from a €22 million EU-funded research project.TruemedincTrueMed & PharmaLedgerTrueMed delivered its non-additive authentication technology for PharmaLedger's anti-counterfeiting use case. PharmaLedger, a public-private project with 29 members under the Innovative Medicines Initiative, concluded its second year. TrueMed plans to continue its collaboration with PharmaLedger in 2022.of Manufacturing MagazineMSD: Building a digital superhighwayMerck Serono (MSD) is implementing a comprehensive digital transformation of its supply chain, leveraging IoT technology from partner TransVoyant and blockchain initiatives through the PharmaLedger consortium to enhance visibility and security. The company is collaborating with distributors like Zuellig Pharma and other pharmaceutical peers to create a connected ecosystem aimed at improving patient access, reducing counterfeiting, and increasing operational resilience.Corriere della SeraBlockchain, ora tutti la vogliono: moda, vaccini e calcio, come funzionaBlockchain adoption accelerated in 2020, with 267 international initiatives from companies and governments, up 59% in concrete projects. Notable projects include Aura Blockchain Consortium for luxury goods, PharmaLedger for vaccine cold-chain, and Sorare for fantasy football.Fortune IndiaCovid-19 vaccine: How ready is India’s supply chain?India's second-phase vaccine deployment faces cold chain logistics gaps, especially in hinterlands, as vaccines require strict temperature ranges. The government has completed assessments and plans to supply additional cold chain equipment, while international partners like UNICEF and WHO provide technical support. Supply chain planners suggest optimizing batch sizes, IoT sensors, and blockchain tracking to address contamination risks.TICpharmaBlockchain dans la pharma: les promesses s'envolent, les cas d'usage restentBlockchain's transformative promises in pharma have not materialized, with only two use cases in production at small scale. Experts cite hype, false experts, and regulatory caution as reasons for industry reluctance.